Why Does My Knockout Cell Line Lose the Phenotype After Passaging?
The Short Answer
The genotype rarely changes. The phenotype fades because the cells adapt:
- Transcriptional adaptation — compensatory programmes restore pathway output.
- Secondary mutations — a subclone with a bypass acquires a growth advantage.
- Silencing of the perturbation — reporter or effector cassettes shut down.
- Selection of escapees — rare unedited or partially edited cells outgrow the population.
Only the fourth is an editing failure; the first three are biology, and all four are testable.
Diagnosing Which One
| Test | What it shows |
|---|---|
| Re-sequence the locus at early and late passage | Whether the edit is intact (tests 2 and 4) |
| Measure the target protein, not mRNA | Whether expression has returned (tests 2 and 3) |
| Check cassette expression (reporter, dCas9) | Silencing (test 3) |
| RNA-seq at early versus late passage | Compensatory programme (test 1) |
| Karyotype or CNV analysis | Secondary genomic changes (test 2) |
A useful first move: freeze an early-passage stock and compare it directly with the late-passage culture. If the early stock shows the phenotype and the late does not, the phenomenon is culture-acquired and worth reporting as such.
Handling Each Cause
Transcriptional adaptation. Report it. A knockout that induces a compensatory programme is a finding about network robustness, and it often explains why the same knockout behaves differently across cell types.
Secondary mutations. Limit passage number, keep early stocks, and periodically re-verify. For long experiments, work from a single thawed batch rather than continuous culture.
Silencing. Use a selection marker, verify cassette expression at the passage used, or switch to a delivery format less prone to silencing.
Escapees. Re-clone from an early stock, increase selection stringency, or use a perturbation that cannot be escaped (a genomic deletion rather than an episomal construct).
Design Rules That Prevent the Problem
- • Define a maximum passage number in the methods and stay within it.
- • Bank early clones in multiple vials before any experiment.
- • Re-verify genotype at the passage used, not only at derivation.
- • Report the passage in every figure legend — a practice that costs nothing and prevents most of this discussion.
Need lines with documented passage stability?
EDITGENE delivers knockout and knockdown clones with genotyping at derivation and at a defined experimental passage, banked early stocks, and passage records — so a fade in phenotype can be attributed rather than guessed.
Tell us the gene and the assay. Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Phenotype drift is common and often biological; absence of a phenotype at late passage does not invalidate an early-passage result, provided both are reported.
Genotype should be re-verified at the passage used for interpretation, and passage numbers should be reported.
Selected references for further reading
- • Ben-David U, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560:325–330.
- • Liu SJ, et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science. 2017;355:eaah7111.
- • Sentmanat MF, et al. A survey of validation strategies for CRISPR-Cas9 editing. Scientific Reports. 2018;8:888.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »